Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | — | — |
Drug ineffective; pneumonia; meningitis; strep; This is a spontaneous report received from an Other HCP. Other Case identifier(s): 02783043 (Merck). A patient (age and gender not provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), in 2022 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown"; PNEUMONIA (medically significant), outcome "unknown"; MENINGITIS (medically significant), outcome "unknown"; STREPTOCOCCAL INFECTION (medically significant), outcome "unknown", described as "strep". The patient was in the hospital with strep, pneumonia, and meningitis. Unknown by reporter what the cause of the hospitalization was. Unknown by reporter what the cause of the strep, pneumonia, and meningitis was. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) will be requested and submitted if and when received.; Sender's Comments: Based on the information currently available, a lack of efficacy with PREVNAR 20 in this patient cannot be completely excluded. Further information like confirmative serotype results and vaccination schedule are needed for full medical assessment..